Find uplifting stories about heroes, innovations, and solutions
284 results for "fda"
%252c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg)
Older adults with leukemia can now take their treatment at home using two pills instead of monthly hospital visits for IV therapy. Nearly half of patients in the trial achieved complete remission with survival rates matching traditional treatment.
A new pill can prevent you from catching COVID after exposure, cutting infection risk by two-thirds. It's the first medication proven to stop the virus before symptoms start.
Researchers at the Weizmann Institute discovered why half of prostate cancers resist treatment and identified a potential solution already approved by the FDA. The breakthrough could transform care for 700,000 men diagnosed with this cancer type annually.
A one-week-old baby received groundbreaking gene therapy for a fatal disease just days after FDA approval, transforming what doctors once called a "death sentence" into a life full of possibility. Today, 10-month-old Samuel is crawling, smiling, and showing no signs of the disease that would have confined him to a wheelchair.
A new combination therapy for aggressive prostate cancer just got FDA approval, along with two tests that help doctors match the right patients to this targeted treatment. This breakthrough could help up to 30% of men with advanced prostate cancer find a treatment plan designed specifically for their genes.
After losing an 11-month-old patient in 1985, neurosurgeon Kevin Tracey spent 40 years developing a tiny implant that tames deadly inflammation. The FDA just approved his device for 1.5 million Americans with rheumatoid arthritis.
A revolutionary drug just doubled survival time for patients with advanced pancreatic cancer, one of the deadliest forms of the disease. Doctors are calling it unprecedented, and the breakthrough could soon help patients with lung, colorectal, and other cancers too.
A new drug has functionally cured chronic hepatitis B in one in five patients, offering hope for the 254 million people living with the world's most common liver infection. The FDA is expected to decide on approval by October 2026.
An experimental pancreatic cancer treatment that helped patients live nearly twice as long as standard chemotherapy is now reaching patients before formal FDA approval. Revolution Medicines began shipping daraxonrasib to physicians this week through a special early access program.
A breakthrough medication called bepirovirsen has functionally cured 20% of chronic hepatitis B patients within one year, marking the first major treatment advance in decades. The FDA is expected to decide on approval this October.
A groundbreaking treatment that could prevent PTSD before it takes hold just cleared a major regulatory hurdle. The FDA has approved human trials for RST-101, a drug designed to stop trauma from becoming chronic psychological distress.
The FDA just approved a new treatment for adults with blastic plasmacytoid dendritic cell neoplasm, an extremely rare and aggressive blood cancer. This marks new hope for patients facing a disease with very few treatment options.
A simple blood test from Singapore just earned breakthrough status from the FDA for detecting 10 types of cancer early. The test has already screened over 100,000 people in Asia with promising results.
A new AI platform turns everyday smartwatches into powerful heart monitors for millions of Americans living with heart failure. The FDA just gave it breakthrough status, potentially preventing countless emergency room visits.
A once-daily pill for sleep apnea is advancing through FDA review after clinical trials showed it reduced breathing disruptions by 44 percent. The experimental drug could offer hope to millions who struggle with CPAP machines, though doctors urge realistic expectations.
Columbia researchers discovered a gene that drives deadly prostate cancer and found an FDA-approved drug that could stop it. The breakthrough offers hope for men whose cancer stops responding to standard treatment.
A newly approved ALS treatment can now target specific genetic causes of the disease, offering hope to patients with Lou Gehrig's disease. The FDA fast-tracked the therapy, marking a significant breakthrough in personalized medicine for neurological conditions.
Three breakthrough breast cancer medications can now be used in earlier disease stages, giving patients better survival rates with fewer side effects. The drugs previously reserved for late-stage cases are now available for stage two and three patients.
A rice-sized implant with living cells is now FDA-approved to slow vision loss in MacTel patients, offering hope to thousands losing their sight. For the first time, people with this rare retinal disease have a real chance to preserve their independence.
A tiny implant no wider than a hair can now free glaucoma patients from daily eyedrops for three full years. Maine patients can get this FDA-approved treatment right in Lewiston without traveling to Boston.
Showing 20 of 284